Literature DB >> 1645770

Severity of human herpesvirus-6 viremia and clinical findings in infants with exanthem subitum.

Y Asano1, T Nakashima, T Yoshikawa, S Suga, T Yazaki.   

Abstract

The degree of viremia with human herpesvirus-6 was evaluated in 176 blood samples from 89 infants with exanthem subitum and viremia, and compared with the severity of clinical features and complications of the disease. Fever persisted for 3 to 4 days in 73% of infants and for more than 5 days in 22%, followed by a rubella- or measles-like rash. The viremia was observed between the first day of fever (day 0) and day 4 of the disease. The number of infected cells per 10 million mononuclear cells was 3.45 +/- 1.00 (log10, mean +/- SD) on days 0 to 2, 3.30 +/- 1.14 on day 3, and 3.09 +/- 2.05 on day 4 of the disease. The number of infected cells on days 3 to 4 in infants with a febrile period longer than 4 days and free virus in plasma was significantly greater than that in infants with a febrile period of less than 3 days and without free virus in plasma. The amount of virus in blood on days 0 to 2 did not relate to the duration of fever, and that on days 0 to 4 did not relate to the presence or absence of diarrhea, bulging fontanelle, or bronchopneumonia. These findings suggest that the magnitude of the virus replication in infants with exanthem subitum is reflected in the severity of the disease.

Entities:  

Mesh:

Year:  1991        PMID: 1645770     DOI: 10.1016/s0022-3476(05)82200-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Clinical characteristics of febrile convulsions during primary HHV-6 infection.

Authors:  S Suga; K Suzuki; M Ihira; T Yoshikawa; Y Kajita; T Ozaki; K Iida; Y Saito; Y Asano
Journal:  Arch Dis Child       Date:  2000-01       Impact factor: 3.791

Review 3.  Human herpesvirus-6 infections.

Authors:  C A Jones; D Isaacs
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

4.  Enhanced allergic sensitisation related to parental smoking.

Authors:  R Ronchetti; E Bonci; R Cutrera; G De Castro; L Indinnimeo; F Midulla; G Tancredi; F D Martinez
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

5.  Detection of human herpesvirus 6 DNA in serum by a microplate PCR-hybridization assay.

Authors:  C Osiowy; I Prud'homme; M Monette; S Zou
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

6.  Detection of human herpesviruses in cerebrospinal fluids collected from patients suspected of neuroinfectious diseases.

Authors:  Soichiro Ishimaru; Yoshiki Kawamura; Hiroki Miura; Sayuri Shima; Akihiro Ueda; Hirohisa Watanabe; Tatsuro Mutoh; Tetsushi Yoshikawa
Journal:  J Neurovirol       Date:  2021-12-30       Impact factor: 2.643

7.  Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals.

Authors:  R W Cone; M L Huang; R Ashley; L Corey
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

8.  Human herpesvirus 7 is a constitutive inhabitant of adult human saliva.

Authors:  L S Wyatt; N Frenkel
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 9.  Hepatitis due to human herpesvirus 6B after hematopoietic cell transplantation and a review of the literature.

Authors:  J A Hill; D Myerson; R H Sedlak; K R Jerome; D M Zerr
Journal:  Transpl Infect Dis       Date:  2014-04-07       Impact factor: 2.228

10.  Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children.

Authors:  Laura Matrajt; Soren Gantt; Bryan T Mayer; Elizabeth M Krantz; Jackson Orem; Anna Wald; Lawrence Corey; Joshua T Schiffer; Corey Casper
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.